Fostriecin sodium

N/A

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameFostriecin sodium

Drug Alias Name福司曲星fostriecinumfostriecinaPD-110161CL-1565A +[7]

ClassificationSmall molecules > Heterocyclic drugs > Antibiotics

Mechanisms of ActionTopoisomerase II inhibitorsProtein phosphatase 2A inhibitors

TargetsTopoisomerase IIProtein phosphatase 2A

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsNeoplasms

ATC CodeN/A